Israel’s Ministry of Health (MOH) has given authorisation to import the Moderna’s COVID-19 vaccine in Israel.
“Today’s authorisation is a landmark moment in our company’s history and in the global fight against COVID-19,” said Stéphane Bancel, CEO of Moderna.
“This is the third regulatory authorisation for the COVID-19 Vaccine Moderna, and its first outside of North America.”
The MOH has secured 6 million doses of the COVID-19 Vaccine Moderna. Planned deliveries reflect today’s authorisation to supply the vaccine in Israel, and first deliveries are expected to begin shortly.
Israel is the third country for which Moderna has received authorisation for its COVID-19 vaccine, following the United States on December 18, 2020 and Canada on December 23, 2020.
Additional authorisations are currently under review in the European Union, Singapore, Switzerland and the United Kingdom.
The decision from the MOH is based on a rolling submission of data and is based on the totality of scientific evidence shared by the company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30.
